Dr. Saveen Semage re-appointed as CEO of NMRA

The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- Six police officers arrested over alleged priest assault granted bail January 29, 2026
- Sri Lanka moves toward ‘Dream School’ system for all grades January 29, 2026
- ASP Rohan Olugala appointed Director of Walana Anti Corruption Unit January 29, 2026
- Sri Lanka launches five-year national action plan to combat human trafficking January 29, 2026
- Équité launches media guidelines to protect LGBTIQ+ rights in Sri Lanka January 28, 2026

